Mitochondria! Dysfunction and Diabetic Retinopathy: Role of Matrix Metalloproteinase-2

被引：0
|
作者：
Mohammad, G., Jr. [1 ]
Kowluru, R. [1 ]
机构：
[1] Kresge Eye Inst, Ophthalmol, Detroit, MI USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2010年 / 51卷 / 13期
关键词：
diabetic retinopathy; mitochondria; apoptosis/cell death;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
5643
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [41] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines
    Afzal, S
    Lalani, EN
    Foulkes, WD
    Boyce, B
    Tickle, S
    Cardillo, MR
    Baker, T
    Pignatelli, M
    Stamp, GWH
    LABORATORY INVESTIGATION, 1996, 74 (02) : 406 - 421
  • [42] Expression of matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in oral squamous cell carcinomas
    Radhakrishnan, R.
    Shrestha, B.
    Bajracharya, D.
    ORAL ONCOLOGY, 2011, 47 : S84 - S84
  • [43] Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium
    Chung, HW
    Lee, JY
    Moon, HS
    Hur, SE
    Park, MH
    Wen, Y
    Polan, ML
    FERTILITY AND STERILITY, 2002, 78 (04) : 787 - 795
  • [44] Matrix metalloproteinase-9 and matrix metalloproteinase-2 in multiple sclerosis
    Benesova, Y.
    Beranek, M.
    Novotna, H.
    Stourac, P.
    Hladikova, M.
    Kadanka, Z.
    Vasku, A.
    Bednarik, J.
    JOURNAL OF NEUROLOGY, 2008, 255 : 114 - 114
  • [45] Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis
    Kang, Shan
    Zhao, Xiwa
    Xing, Huimin
    Wang, Na
    Zhou, Rongmiao
    Chen, Shucheng
    Li, Wansheng
    Zhao, Jian
    Duan, Yanan
    Sun, Donglan
    Li, Yan
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2008, 49 (03) : 226 - 231
  • [46] HIGHER DIALYSATE MATRIX METALLOPROTEINASE-2 LEVELS ARE ASSOCIATED WITH PERITONEAL MEMBRANE DYSFUNCTION
    Cho, Yeoungjee
    Johnson, David W.
    Vesey, David A.
    Hawley, Carmel M.
    Pascoe, Elaine M.
    Clarke, Margaret
    Topley, Nicholas
    PERITONEAL DIALYSIS INTERNATIONAL, 2016, 36 (01): : 16 - 25
  • [47] Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction
    Gao, CQ
    Sawicki, G
    Suarez-Pinzon, WL
    Csont, T
    Wozniak, M
    Ferdinandy, P
    Schulz, R
    CARDIOVASCULAR RESEARCH, 2003, 57 (02) : 426 - 433
  • [48] Increased circulating matrix metalloproteinase-2 in patients with hypertrophic cardiomyopathy with systolic dysfunction
    Noji, Y
    Shimizu, M
    Higashikata, T
    Yamaguchi, M
    Nohara, A
    Horita, T
    Shimizu, K
    Ito, Y
    Matsuda, T
    Namura, M
    Mabuchi, H
    Mabuchi, H
    CIRCULATION JOURNAL, 2004, 68 (04) : 355 - 360
  • [49] Prognostic value of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in bladder carcinoma
    Xu, KX
    Hou, SK
    Du, ZJ
    CHINESE MEDICAL JOURNAL, 2002, 115 (05) : 743 - 745
  • [50] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in colorectal carcinoma invasion and metastasis
    Li, Bing-Hui
    Zhao, Peng
    Liu, Shi-Zheng
    Yu, Yue-Ming
    Han, Mei
    Wen, Jin-Kun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (20) : 3046 - 3050
12345